Research output per year
Research output per year
Fingerprint
Dive into the research topics where Diana P Castro is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A CADM3 variant causes Charcot-Marie-Tooth disease with marked upper limb involvement
Rebelo, A. P., Cortese, A., Abraham, A., Eshed-Eisenbach, Y., Shner, G., Vainshtein, A., Buglo, E., Camarena, V., Gaidosh, G., Shiekhattar, R., Abreu, L., Courel, S., Burns, D. K., Bai, Y., Bacon, C., Feely, S. M. E., Castro, DI., Peles, E., Reilly, M. M., Shy, M. E. & 1 others, , Apr 1 2021, In: Brain. 144, 4, p. 1197-1213 17 p.Research output: Contribution to journal › Article › peer-review
-
Delivery of Nusinersen Through an Ommaya Reservoir in Spinal Muscular Atrophy
Iannaccone, S. T., Paul, D., Castro, D., Weprin, B. E. & Swift, D., Mar 1 2021, In: Journal of Clinical Neuromuscular Disease. 22, 3, p. 129-134 6 p.Research output: Contribution to journal › Article › peer-review
-
Loss of function mutations in GEMIN5 cause a neurodevelopmental disorder
Kour, S., Rajan, D. S., Fortuna, T. R., Anderson, E. N., Ward, C., Lee, Y., Lee, S., Shin, Y. B., Chae, J. H., Choi, M., Siquier, K., Cantagrel, V., Amiel, J., Stolerman, E. S., Barnett, S. S., Cousin, M. A., Castro, D., McDonald, K., Kirmse, B., Nemeth, A. H. & 50 others, , Dec 2021, In: Nature communications. 12, 1, 2558.Research output: Contribution to journal › Article › peer-review
Open Access -
Safety and efficacy of nusinersen in spinal muscular atrophy: The EMBRACE study
Acsadi, G., Crawford, T. O., Müller-Felber, W., Shieh, P. B., Richardson, R., Natarajan, N., Castro, D., Ramirez-Schrempp, D., Gambino, G., Sun, P. & Farwell, W., May 2021, In: Muscle and Nerve. 63, 5, p. 668-677 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Efficacy and safety of vamorolone in Duchenne muscular dystrophy: An 18-month interim analysis of a non-randomized open-label extension study
CINRG VBP15 and DNHS Investigators, Sep 2020, In: PLoS Medicine. 17, 9, 1003222.Research output: Contribution to journal › Article › peer-review
Open Access